SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-17-021801
Filing Date
2017-04-25
Accepted
2017-04-24 20:05:18
Documents
1
Group Members
FORESITE CAPITAL MANAGEMENT III, LLC (FCM III)JAMES TANANBAUM (TANANBAUM)

Document Format Files

Seq Description Document Type Size
1 SC 13G v464970_sc13g.htm SC 13G 70280
  Complete submission text file 0001144204-17-021801.txt   71899
Mailing Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109
Business Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400
Tocagen Inc (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89959 | Film No.: 17779370
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund III, L.P. (Filed by) CIK: 0001645158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G